CD14 and TRIF govern distinct responsiveness and responses in mouse microglial TLR4 challenges by structural variants of LPS

Brain, Behavior, and Immunity

Volumn 25, Issue 5, 2011, Pages 957-970

  Regen, Tommy ^a   van Rossum, Denise ^a   Scheffel, Jörg ^a   Kastriti, Maria Eleni ^a   Revelo, Natalia H ^a   Prinz, Marco ^b   Brück, Wolfgang ^a   Hanisch, Uwe Karsten ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

CD14; DAMP; LPS; MHC I; MyD88; PAMP; Phagocytosis; TLR4; TRIF

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CD14 ANTIGEN; CHEMOKINE; CXCL1 CHEMOKINE; CYTOKINE; FIBRONECTIN; INTERLEUKIN 12P40; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELIN; MYELOID DIFFERENTIATION FACTOR 88; RANTES; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CELL TYPE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNE RESPONSE; IMMUNOMODULATION; MACROPHAGE; MICROGLIA; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; ANTIGENS, CD14; AVIAN PROTEINS; CELLS, CULTURED; CYTOKINES; FLOW CYTOMETRY; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; MICE, INBRED C57BL; MICROGLIA; PHAGOCYTOSIS; TOLL-LIKE RECEPTOR 4;

EID: 79957915948     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2010.10.009     Document Type: Article

References (75)

1. Adachi O., Kawai T., Takeda K., Matsumoto M., Tsutsui H., Sakagami M., Nakanishi K., Akira S. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 1998, 9:143-150.
2. Akashi S., Nagai Y., Ogata H., Oikawa M., Fukase K., Kusumoto S., Kawasaki K., Nishijima M., Hayashi S., Kimoto M., Miyake K. Human MD-2 confers on mouse Toll-like receptor 4 species-specific lipopolysaccharide recognition. Int. Immunol. 2001, 13:1595-1599.
3. Baccala R., Hoebe K., Kono D.H., Beutler B., Theofilopoulos A.N. TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity. Nat. Med. 2007, 13:543-551.
4. Beschorner R., Nguyen T.D., Gozalan F., Pedal I., Mattern R., Schluesener H.J., Meyermann R., Schwab J.M. CD14 expression by activated parenchymal microglia/macrophages and infiltrating monocytes following human traumatic brain injury. Acta Neuropathol. 2002, 103:541-549.
5. Beutler B., Rietschel E.T. Innate immune sensing and its roots, the story of endotoxin. Nat. Rev. Immunol. 2003, 3:169-176.
6. Cauwels A., Frei K., Sansano S., Fearns C., Ulevitch R., Zimmerli W., Landmann R. The origin and function of soluble CD14 in experimental bacterial meningitis. J. Immunol. 1999, 162:4762-4772.
7. Coats S.R., Pham T.T., Bainbridge B.W., Reife R.A., Darveau R.P. MD-2 mediates the ability of tetra-acylated and penta-acylated lipopolysaccharides to antagonize Escherichia coli lipopolysaccharide at the TLR4 signaling complex. J. Immunol. 2005, 175:4490-4498.
8. Cullheim S., Thams S. The microglial networks of the brain and their role in neuronal network plasticity after lesion. Brain Res. Rev. 2007, 55:89-96.
9. Doyle S.L., O'Neill L.A. Toll-like receptors, from the discovery of NFκB to new insights into transcriptional regulations in innate immunity. Biochem. Pharmacol. 2006, 72:1102-1113.
10. Erridge C., nett-Guerrero E., Poxton I.R. Structure and function of lipopolysaccharides. Microbes Infect. 2002, 4:837-851.
11. Gangloff S.C., Zahringer U., Blondin C., Guenounou M., Silver J., Goyert S.M. Influence of CD14 on ligand interactions between lipopolysaccharide and its receptor complex. J. Immunol. 2005, 175:3940-3945.
12. Garg, S., Nichols, J.R., Esen, N., Liu, S., Phulwani, N.K., Syed, M.M., Wood, W.H., Zhang, Y., Becker, K.G., Aldrich, A., Kielian, T., 2009. MyD88 expression by CNS-resident cells is pivotal for eliciting protective immunity in brain abscesses. ASN Neuro. 1.
13. Gay N.J., Gangloff M., Weber A.N. Toll-like receptors as molecular switches. Nat. Rev. Immunol. 2006, 6:693-698.
14. Glezer I., Lapointe A., Rivest S. Innate immunity triggers oligodendrocyte progenitor reactivity and confines damages to brain injuries. FASEB J. 2006, 20:750-752.
15. Godowski P.J. A smooth operator for LPS responses. Nat. Immunol. 2005, 6:544-546.
16. Goos M., Lange P., Hanisch U.K., Prinz M., Scheffel J., Bergmann R., Ebert S., Nau R. Fibronectin is elevated in the cerebrospinal fluid of patients suffering from bacterial meningitis and enhances inflammation caused by bacterial products in primary mouse microglial cell cultures. J. Neurochem. 2007, 102:2049-2060.
17. Hanisch U.K., Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 2007, 10:1387-1394.
18. Hanisch U.K., Prinz M., Angstwurm K., Häusler K.G., Kann O., Kettenmann H., Weber J.R. The protein tyrosine kinase inhibitor AG126 prevents the massive microglial cytokine induction by pneumococcal cell walls. Eur. J. Immunol. 2001, 31:2104-2115.
19. Hanisch U.K., Johnson T.V., Kipnis J. Toll-like receptors: roles in neuroprotection?. Trends Neurosci. 2008, 31:176-182.
20. Harju K., Ojaniemi M., Rounioja S., Glumoff V., Paananen R., Vuolteenaho R., Hallman M. Expression of toll-like receptor 4 and endotoxin responsiveness in mice during perinatal period. Pediatr. Res. 2005, 57:644-648.
21. Häusler K.G., Prinz M., Nolte C., Weber J.R., Schumann R.R., Kettenmann H., Hanisch U.K. Interferon-γ differentially modulates the release of cytokines and chemokines in lipopolysaccharide- and pneumococcal cell wall-stimulated mouse microglia and macrophages. Eur. J. NeuroSci. 2002, 16:2113-2122.
22. Haziot A., Ferrero E., Kontgen F., Hijiya N., Yamamoto S., Silver J., Stewart C.L., Goyert S.M. Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. Immunity 1996, 4:407-414.
23. Hoebe K., Du X., Georgel P., Janssen E., Tabeta K., Kim S.O., Goode J., Lin P., Mann N., Mudd S., Crozat K., Sovath S., Han J., Beutler B. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 2003, 424:743-748.
24. Huber M., Kalis C., Keck S., Jiang Z., Georgel P., Du X., Shamel L., Sovath S., Mudd S., Beutler B., Galanos C., Freudenberg M.A. R-form LPS, the master key to the activation ofTLR4/MD-2-positive cells. Eur. J. Immunol. 2006, 36:701-711.
25. Jiang Z., Georgel P., Du X., Shamel L., Sovath S., Mudd S., Huber M., Kalis C., Keck S., Galanos C., Freudenberg M., Beutler B. CD14 is required for MyD88-independent LPS signaling. Nat. Immunol. 2005, 6:565-570.
26. Kagan J.C., Medzhitov R. Phosphoinositide-mediated adaptor recruitment controls Toll-like receptor signaling. Cell 2006, 125:943-955.
27. Kagan J.C., Su T., Horng T., Chow A., Akira S., Medzhitov R. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-β. Nat. Immunol. 2008, 9:361-368.
28. Kawai T., Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 2010, 11:373-384.
29. Kawai T., Adachi O., Ogawa T., Takeda K., Akira S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 1999, 11:115-122.
30. Kim H.M., Park B.S., Kim J.I., Kim S.E., Lee J., Oh S.C., Enkhbayar P., Matsushima N., Lee H., Yoo O.J., Lee J.O. Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell 2007, 130:906-917.
31. Kirikae T., Schade F.U., Kirikae F., Qureshi N., Takayama K., Rietschel E.T. Diphosphoryl lipid A derived from the lipopolysaccharide (LPS) of Rhodobacter sphaeroides ATCC 17023 is a potent competitive LPS inhibitor in murine macrophage-like J774.1 cells. FEMS Immunol. Med. Microbiol. 1994, 9:237-243.
32. Kobayashi M., Saitoh S., Tanimura N., Takahashi K., Kawasaki K., Nishijima M., Fujimoto Y., Fukase K., kashi-Takamura S., Miyake K. Regulatory roles for MD-2 and TLR4 in ligand-induced receptor clustering. J. Immunol. 2006, 176:6211-6218.
33. Kono H., Rock K.L. How dying cells alert the immune system to danger. Nat. Rev. Immunol. 2008, 8:279-289.
34. Krishnan J., Selvarajoo K., Tsuchiya M., Lee G., Choi S. Toll-like receptor signal transduction. Exp. Mol. Med. 2007, 39:421-438.
35. Lehnardt S., Lachance C., Patrizi S., Lefebvre S., Follett P.L., Jensen F.E., Rosenberg P.A., Volpe J.J., Vartanian T. The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS. J. Neurosci. 2002, 22:2478-2486.
36. Lehnardt S., Schott E., Trimbuch T., Laubisch D., Krueger C., Wulczyn G., Nitsch R., Weber J.R. A vicious cycle involving release of heat shock protein 60 from injured cells and activation of toll-like receptor 4 mediates neurodegeneration in the CNS. J. Neurosci. 2008, 28:2320-2331.
37. Lohmann K.L., Vandenplas M.L., Barton M.H., Bryant C.E., Moore J.N. The equine TLR4/MD-2 complex mediates recognition of lipopolysaccharide from Rhodobacter sphaeroides as an agonist. J. Endotoxin Res. 2007, 13:235-242.
38. Lotze M.T., Zeh H.J., Rubartelli A., Sparvero L.J., Amoscato A.A., Washburn N.R., Devera M.E., Liang X., Tor M., Billiar T. The grateful dead: damage-associated molecular pattern molecules and reduction/oxidation regulate immunity. Immunol. Rev. 2007, 220:60-81.
39. Mata-Haro V., Cekic C., Martin M., Chilton P.M., Casella C.R., Mitchell T.C. The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4. Science 2007, 316:1628-1632.
40. Matzinger P. Friendly and dangerous signals: is the tissue in control?. Nat. Immunol. 2007, 8:11-13.
41. Milanski M., Degasperi G., Coope A., Morari J., Denis R., Cintra D.E., Tsukumo D.M., Anhe G., Amaral M.E., Takahashi H.K., Curi R., Oliveira H.C., Carvalheira J.B., Bordin S., Saad M.J., Velloso L.A. Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus: implications for the pathogenesis of obesity. J. Neurosci. 2009, 29:359-370.
42. Miller S.I., Ernst R.K., Bader M.W. LPS, TLR4 and infectious disease diversity. Nat. Rev. Microbiol. 2005, 3:36-46.
43. Nimmerjahn A., Kirchhoff F., Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 2005, 308:1314-1318.
44. Ohto U., Fukase K., Miyake K., Satow Y. Crystal structures of human MD-2 and its complex with antiendotoxic lipid IVa. Science 2007, 316:1632-1634.
45. Olson J.K., Miller S.D. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J. Immunol. 2004, 173:3916-3924.
46. O'Neill L.A., Bowie A.G. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat. Rev. Immunol. 2007, 7:353-364.
47. Park B.S., Song D.H., Kim H.M., Choi B.S., Lee H., Lee J.O. The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature 2009, 458:1191-1195.
48. Radisky D.C., Stallings-Mann M., Hirai Y., Bissell M.J. Single proteins might have dual but related functions in intracellular and extracellular microenvironments. Nat. Rev. Mol. Cell Biol. 2009, 10:228-234.
49. Raetz C.R., Whitfield C. Lipopolysaccharide endotoxins. Annu. Rev. Biochem. 2002, 71:635-700.
50. Reed-Geaghan E.G., Savage J.C., Hise A.G., Landreth G.E. CD14 and toll-like receptors 2 and 4 are required for fibrillar Aβ-stimulated microglial activation. J. Neurosci. 2009, 29:11982-11992.
51. Ribes S., Ebert S., Czesnik D., Regen T., Zeug A., Bukowski S., Mildner A., Eiffert H., Hanisch U.K., Hammerschmidt S., Nau R. Toll-like receptor prestimulation increases phagocytosis of Escherichia coli DH5alpha and Escherichia coli K1 strains by murine microglial cells. Infect. Immun. 2009, 77:557-564.
52. Ribes S., Ebert S., Regen T., Agarwal A., Tauber S.C., Czesnik D., Spreer A., Bunkowski S., Eiffert H., Hanisch U.K., Hammerschmidt S., Nau R. Toll-like receptor stimulation enhances phagocytosis and intracellular killing of nonencapsulated and encapsulated Streptococcus pneumoniae by murine microglia. Infect. Immun. 2010, 78:865-871.
53. Ribes S., Ebert S., Regen T., Czesnik D., Scheffel J., Zeug A., Bunkowski S., Eiffert H., Hanisch U.K., Hammerschmidt S., Nau R. Fibronectin stimulates Escherichia coli phagocytosis by microglial cells. Glia 2010, 58:367-376.
54. Rivest S. Regulation of innate immune responses in the brain. Nat. Rev. Immunol. 2009, 9:429-439.
55. Rolls A., Shechter R., London A., Ziv Y., Ronen A., Levy R., Schwartz M. Toll-like receptors modulate adult hippocampal neurogenesis. Nat. Cell Biol. 2007, 9:1081-1088.
56. Rubartelli A., Lotze M.T. Inside, outside, upside down: damage-associated molecular pattern molecules (DAMPs) and redox. Trends Immunol. 2007, 28:429-436.
57. Saitoh S., Akashi S., Yamada T., Tanimura N., Kobayashi M., Konno K., Matsumoto F., Fukase K., Kusumoto S., Nagai Y., Kusumoto Y., Kosugi A., Miyake K. Lipid A antagonist, lipid IVa, is distinct from lipid A in interaction with Toll-like receptor 4 (TLR4)-MD-2 and ligand-induced TLR4 oligomerization. Int. Immunol. 2004, 16:961-969.
58. Schwartz M., Butovsky O., Brück W., Hanisch U.K. Microglial phenotype: is the commitment reversible?. Trends Neurosci. 2006, 29:68-74.
59. Srikrishna G., Freeze H.H. Endogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancer. Neoplasia 2009, 11:615-628.
60. Stenutz R., Weintraub A., Widmalm G. The structures of Escherichia coli O-polysaccharide antigens. FEMS Microbiol. Rev. 2006, 30:382-403.
61. Stewart C.R., Stuart L.M., Wilkinson K., van Gils J.M., Deng J., Halle A., Rayner K.J., Boyer L., Zhong R., Frazier W.A., Lacy-Hulbert A., El K.J., Golenbock D.T., Moore K.J. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat. Immunol. 2010, 11:155-161.
62. Teghanemt A., Zhang D., Levis E.N., Weiss J.P., Gioannini T.L. Molecular basis of reduced potency of underacylated endotoxins. J. Immunol. 2005, 175:4669-4676.
63. Triantafilou M., Triantafilou K. Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster. Trends Immunol. 2002, 23:301-304.
64. Triantafilou M., Brandenburg K., Kusumoto S., Fukase K., Mackie A., Seydel U., Triantafilou K. Combinational clustering of receptors following stimulation by bacterial products determines lipopolysaccharide responses. Biochem. J. 2004, 381:527-536.
65. Trinchieri G., Sher A. Cooperation of Toll-like receptor signals in innate immune defence. Nat. Rev. Immunol. 2007, 7:179-190.
66. Tschop M., Thomas G. Fat fuels insulin resistance through Toll-like receptors. Nat. Med. 2006, 12:1359-1361.
67. van Rossum D., Hilbert S., Strassenburg S., Hanisch U.K., Brück W. Myelin-phagocytosing macrophages in isolated sciatic and optic nerves reveal a unique reactive phenotype. Glia 2008, 56:271-283.
68. Visintin A., Halmen K.A., Latz E., Monks B.G., Golenbock D.T. Pharmacological inhibition of endotoxin responses is achieved by targeting the TLR4 coreceptor, MD-2. J. Immunol. 2005, 175:6465-6472.
69. Vogl T., Tenbrock K., Ludwig S., Leukert N., Ehrhardt C., van Zoelen M.A., Nacken W., Foell D., van der P.T., Sorg C., Roth J. Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat. Med. 2007, 13:1042-1049.
70. Wake H., Moorhouse A.J., Jinno S., Kohsaka S., Nabekura J. Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals. J. Neurosci. 2009, 29:3974-3980.
71. Werling D., Jann O.C., Offord V., Glass E.J., Coffey T.J. Variation matters: TLR structure and species-specific pathogen recognition. Trends Immunol. 2009, 30:124-130.
72. Wong K.F., Luk J.M., Cheng R.H., Klickstein L.B., Fan S.T. Characterization of two novel LPS-binding sites in leukocyte integrin βA domain. FASEB J. 2007, 21:3231-3239.
73. Zanoni I., Ostuni R., Capuano G., Collini M., Caccia M., Ronchi A.E., Rocchetti M., Mingozzi F., Foti M., Chirico G., Costa B., Zaza A., Ricciardi-Castagnoli P., Granucci F. CD14 regulates the dendritic cell life cycle after LPS exposure through NFAT activation. Nature 2009, 460:264-268.
74. Zhang X., Mosser D.M. Macrophage activation by endogenous danger signals. J. Pathol. 2008, 214:161-178.
75. Zughaier S.M., Zimmer S.M., Datta A., Carlson R.W., Stephens D.S. Differential induction of the toll-like receptor 4-MyD88-dependent and -independent signaling pathways by endotoxins. Infect. Immun. 2005, 73:2940-2950.